2020. Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital. Indian Journal of Forensic Medicine & Toxicology. 14, 2 (Apr. 2020), 2505–2510. DOI:https://doi.org/10.37506/ijfmt.v14i2.3485.